EUVIMEDEUVIMED entdecken
Crossref

The Visceral Fat–Muscle Trade‐off in Obese Chronic Liver Disease: Insights From SMA‐Level Periportal VAT

Atsushi Nakamura iD, Takeshi Ichikawa iD, Keiji Okuyama

Hepatology Research · 2026-11 · 56 (11) · 1723-1736

DOI: 10.1111/hepr.70249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 21.07.2026. Verfasst von Atsushi Nakamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterological Liver Disease Center, Nippon Koukan Hospital, Kawasaki, Japan. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Visceral adipose tissue (VAT) contributes to MASLD pathophysiology via the portal circulation, and weight loss is a cornerstone of treatment; however, its effect on skeletal muscle remains unclear. This study evaluated intra‐abdominal area (IAA) at the superior mesenteric artery (SMA) level—a site capturing periportal adipose tissue—and examined the association between weight loss and muscle loss in non‐cirrhotic obese chronic liver disease (CLD).

Methods

IAA and paraspinal muscle area were quantified by MRI at the SMA level. Longitudinal changes in IAA, muscle mass, proton density fat fraction (PDFF), ALT, and liver stiffness (LS) were annualized. Cross‐sectional associations were evaluated in the overall cohort (BMI ≥ 25 kg/m 2 , n = 286); longitudinal relationships were assessed in CLD undergoing lifestyle intervention ( n = 141, median follow‐up: 36 months).

Results

In the cohort (MASLD 60%), IAA was independently associated with lower muscle mass and higher LS beyond FIB‐4. In the longitudinal cohort, IAA reduction was independently associated with improvements in PDFF and LS, whereas muscle mass declined nonlinearly with greater IAA reduction ( R 2 = 0.336, p < 0.001). In MASLD, a ≥ 4% IAA reduction significantly improved PDFF, ALT, and LS but was accompanied by muscle loss (−3.9%/y), whereas albumin remained unchanged ( p = 0.968).

Conclusions

In obese CLD, IAA at the SMA level serves as a practical marker of periportal VAT. Although its reduction benefits the liver, it may be accompanied by muscle loss. Preserved serum albumin does not exclude ongoing skeletal muscle catabolism. Enhanced protein intake during weight loss may help mitigate muscle catabolism.

Schlagwörter

Stichwörter der Autor:innen

MASLDmagnetic resonance imagingskeletal muscle lossvisceral adipose tissueweight reduction

Autor:innen und Institutionen

  • Gastroenterological Liver Disease Center, Nippon Koukan Hospital, Kawasaki, Japan.

ORCID-Profile: Atsushi Nakamura, Takeshi Ichikawa

Zitieren

APA

Nakamura, A., Ichikawa, T., & Okuyama, K. (2026). The Visceral Fat–Muscle Trade‐off in Obese Chronic Liver Disease: Insights From SMA‐Level Periportal VAT. Hepatology Research, 56(11), 1723-1736. https://doi.org/10.1111/hepr.70249

Vancouver

Nakamura A, Ichikawa T, Okuyama K. The Visceral Fat–Muscle Trade‐off in Obese Chronic Liver Disease: Insights From SMA‐Level Periportal VAT. Hepatology Research. 2026;56(11):1723-1736. doi:10.1111/hepr.70249

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Atsushi and Ichikawa, Takeshi and Okuyama, Keiji},
  title = {The Visceral Fat–Muscle Trade‐off in Obese Chronic Liver Disease: Insights From SMA‐Level Periportal VAT},
  journal = {Hepatology Research},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1723--1736},
  doi = {10.1111/hepr.70249}
}
Kostenlos starten →